NCNbio is a company focused on the Industrial Tech Transfer in biotechnology
20 January 2021
Complexity and innovation of Advanced Therapies require a careful and ethical communication.
This will be discussed at the online webinar and ECM training course “Dal laboratorio al paziente. Raccontare il viaggio delle Terapie Avanzate”, organized by Osservatorio Terapie Avanzate.
Our CEO Maria Luisa Nolli, as member of Assobiotec, will explain how an advanced medicine is it done.
Maria Luisa Nolli, is attending the online workshop organized by 2i3T, business incubator of University of Turin. As member of the board and head of the R&D group in AFI (Associazione Farmaceutici dell’Industria) she will discuss about the italian Cell Factories authorised for the production of Advanced Therapy Medicinal Products and the future of these medicines both in Italy and in Europe.
“Advanced Therapies Medicinal Products: The Revolution in medicine, from blockbusters to a personalized medicine. In this context, the QP has an interdisciplinary role in all activities of a Cell Factory, a fundamental starting point for this job in the future.”
The speech of Maria Luisa Nolli at the webinar organized by AFI, XIV INCONTRO NAZIONALE DELLE PERSONE QUALIFICATE (QP) IN AMBITO FARMACEUTICO.